[Cerebrospinal fluid neurotransmitter screening in encephalopathies]
Oubiña M, Ciapponi A Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A.
Record ID 32018001403
Original Title: Dosaje de neurotransmisores en líquido cefalorraquídeo en encefalopatías
Authors' recommendations: CONCLUSIONS The evidence on the usefulness of screening neurotransmitters in cerebrospinal fluid in encephalopathies is of very low quality. No studies comparing this technology with other usual diagnostic methods such as clinical criteria or imaging intended for differential diagnoses among the different entities associated to chronic encephalopathies or generalized development disorder have been found. Only one consensus recommending its use in case of the aromatic L-amino acid decarboxylase deficiency has been found. No coverage policies on the use of this technology have been found.
Project Status: Completed
Year Published: 2017
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Brain Diseases, Metabolic, Inborn
- Cerebrospinal Fluid
- Brain Diseases, Metabolic
- Neurotransmitter Agents
- Brain Diseases
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.